ReP USP - Resultado da busca

Artigo de periodico
Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response (2013)
Rodrigues, Alice Cristina ; Sobrino, B; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Bertolami, Marcelo; Faludi, André Arpad; Brion, M. J; Carracedo, Angel; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Clinica Chimica Acta. Unidades: HU, FCF
Subjects: DISLIPIDEMIAS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina et al. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response. Clinica Chimica Acta, v. 417, n. 1, p. 8-11, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2012.11.028. Acesso em: 06 nov. 2024.
APA
Rodrigues, A. C., Sobrino, B., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., Dórea, E. L., et al. (2013). Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response. Clinica Chimica Acta, 417( 1), 8-11. doi:10.1016/j.cca.2012.11.028
NLM
Rodrigues AC, Sobrino B, Genvigir FDV, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Bertolami M, Faludi AA, Brion MJ, Carracedo A, Hirata MH, Hirata RDC. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response [Internet]. Clinica Chimica Acta. 2013 ; 417( 1): 8-11.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cca.2012.11.028
Vancouver
Rodrigues AC, Sobrino B, Genvigir FDV, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Bertolami M, Faludi AA, Brion MJ, Carracedo A, Hirata MH, Hirata RDC. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response [Internet]. Clinica Chimica Acta. 2013 ; 417( 1): 8-11.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cca.2012.11.028
Artigo de periodico
Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients (2013)
Willrich, Maria Alice Vieira; Rodrigues, Alice Cristina ; Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Arazi, Simone Sorkin; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Bertolami, Marcelo Chiara; Faludi, André Arpad; Largura, Alvaro; Baudhuin, Linnea M; Bryant, Sandra C; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Clinica Chimica Acta. Unidades: HU, FCF
Subjects: EXPRESSÃO GÊNICA, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLRICH, Maria Alice Vieira et al. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients. Clinica Chimica Acta, v. 421, p. 157-163, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2013.03.007. Acesso em: 06 nov. 2024.
APA
Willrich, M. A. V., Rodrigues, A. C., Cerda, A., Genvigir, F. D. V., Arazi, S. S., Dórea, E. L., et al. (2013). Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients. Clinica Chimica Acta, 421, 157-163. doi:10.1016/j.cca.2013.03.007
NLM
Willrich MAV, Rodrigues AC, Cerda A, Genvigir FDV, Arazi SS, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Largura A, Baudhuin LM, Bryant SC, Hirata MH, Hirata RDC. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients [Internet]. Clinica Chimica Acta. 2013 ; 421 157-163.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cca.2013.03.007
Vancouver
Willrich MAV, Rodrigues AC, Cerda A, Genvigir FDV, Arazi SS, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Largura A, Baudhuin LM, Bryant SC, Hirata MH, Hirata RDC. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients [Internet]. Clinica Chimica Acta. 2013 ; 421 157-163.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cca.2013.03.007
Artigo de periodico
Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin (2010)
Cerda, Álvaro; Genvigir, Fabiana Dalla Vecchia; Arazi, Simone Sorkin; Hirata, Mario Hiroyuki ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Bertolami, Marcelo Chiara; Faludi, Andre Arpad; Hirata, Rosario Dominguez Crespo
Source: Clinica Chimica Acta. Unidades: FCF, HU
Subjects: FARMACOGENÉTICA, POLIMORFISMO, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Álvaro et al. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin. Clinica Chimica Acta, v. 411, n. 9-10, p. 631-637, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2010.01.002. Acesso em: 06 nov. 2024.
APA
Cerda, Á., Genvigir, F. D. V., Arazi, S. S., Hirata, M. H., Dórea, E. L., Bernik, M. M. S., et al. (2010). Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin. Clinica Chimica Acta, 411( 9-10), 631-637. doi:10.1016/j.cca.2010.01.002
NLM
Cerda Á, Genvigir FDV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Hirata RDC. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin [Internet]. Clinica Chimica Acta. 2010 ; 411( 9-10): 631-637.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cca.2010.01.002
Vancouver
Cerda Á, Genvigir FDV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Hirata RDC. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin [Internet]. Clinica Chimica Acta. 2010 ; 411( 9-10): 631-637.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cca.2010.01.002
Artigo de periodico
Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response (2008)
Arazi, Simone Sorkin; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Hirata, Mario Hiroyuki ; Dorea, Egidio Lima; Bernik, Márcia Martins Silveira; Hirata, Rosario Dominguez Crespo
Source: Clinica Chimica Acta. Unidades: FCF, HU
Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAZI, Simone Sorkin et al. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response. Clinica Chimica Acta, v. 393, n. 2, p. 119-124, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2008.03.031. Acesso em: 06 nov. 2024.
APA
Arazi, S. S., Genvigir, F. D. V., Willrich, M. A. V., Hirata, M. H., Dorea, E. L., Bernik, M. M. S., & Hirata, R. D. C. (2008). Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response. Clinica Chimica Acta, 393( 2), 119-124. doi:10.1016/j.cca.2008.03.031
NLM
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response [Internet]. Clinica Chimica Acta. 2008 ; 393( 2): 119-124.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cca.2008.03.031
Vancouver
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response [Internet]. Clinica Chimica Acta. 2008 ; 393( 2): 119-124.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cca.2008.03.031
Artigo de periodico
Effects of ABCA1 SNPs, including the C-105T novel variant, on serum lipids of Brazilian individuals (2008)
Genvigir, Fabiana Dalla Vecchia; Soares, Sarah Aparecida; Hirata, Mario Hiroyuki ; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Rebecchi, Ivanise Marina Moretti; Oliveira, Raquel; Bernik, Marcia Martins Silveira; Dorea, Egidio Lima; Bertolami, Marcelo C.; Hirata, Rosario Dominguez Crespo
Source: Clinica Chimica Acta. Unidades: FCF, HU
Subjects: FARMACOGENÉTICA, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. Effects of ABCA1 SNPs, including the C-105T novel variant, on serum lipids of Brazilian individuals. Clinica Chimica Acta, v. 389, n. 1-2, p. 79-86, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2007.11.029. Acesso em: 06 nov. 2024.
APA
Genvigir, F. D. V., Soares, S. A., Hirata, M. H., Willrich, M. A. V., Arazi, S. S., Rebecchi, I. M. M., et al. (2008). Effects of ABCA1 SNPs, including the C-105T novel variant, on serum lipids of Brazilian individuals. Clinica Chimica Acta, 389( 1-2), 79-86. doi:10.1016/j.cca.2007.11.029
NLM
Genvigir FDV, Soares SA, Hirata MH, Willrich MAV, Arazi SS, Rebecchi IMM, Oliveira R, Bernik MMS, Dorea EL, Bertolami MC, Hirata RDC. Effects of ABCA1 SNPs, including the C-105T novel variant, on serum lipids of Brazilian individuals [Internet]. Clinica Chimica Acta. 2008 ; 389( 1-2): 79-86.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cca.2007.11.029
Vancouver
Genvigir FDV, Soares SA, Hirata MH, Willrich MAV, Arazi SS, Rebecchi IMM, Oliveira R, Bernik MMS, Dorea EL, Bertolami MC, Hirata RDC. Effects of ABCA1 SNPs, including the C-105T novel variant, on serum lipids of Brazilian individuals [Internet]. Clinica Chimica Acta. 2008 ; 389( 1-2): 79-86.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cca.2007.11.029
Artigo de periodico
CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia (2008)
Willrich, Maria Alice Vieira; Hirata, Mario Hiroyuki ; Genvigir, Fabiana Dalla Vecchia; Arazi, Simone Sorkin; Rebecchi, Ivanise Marina Moretti; Rodrigues, Alice Cristina ; Bernik, Marcia Martins Silveira; Dórea, Egidio Lima; Bertolami, Marcelo Chiara; Faludi, André Arpad; Hirata, Rosario Dominguez Crespo
Source: Clinica Chimica Acta. Unidades: FCF, HU
Subjects: HIPERCOLESTEROLEMIA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLRICH, Maria Alice Vieira et al. CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia. Clinica Chimica Acta, v. 398, n. 1-2, p. 15-20, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2008.07.032. Acesso em: 06 nov. 2024.
APA
Willrich, M. A. V., Hirata, M. H., Genvigir, F. D. V., Arazi, S. S., Rebecchi, I. M. M., Rodrigues, A. C., et al. (2008). CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia. Clinica Chimica Acta, 398( 1-2), 15-20. doi:10.1016/j.cca.2008.07.032
NLM
Willrich MAV, Hirata MH, Genvigir FDV, Arazi SS, Rebecchi IMM, Rodrigues AC, Bernik MMS, Dórea EL, Bertolami MC, Faludi AA, Hirata RDC. CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia [Internet]. Clinica Chimica Acta. 2008 ; 398( 1-2): 15-20.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cca.2008.07.032
Vancouver
Willrich MAV, Hirata MH, Genvigir FDV, Arazi SS, Rebecchi IMM, Rodrigues AC, Bernik MMS, Dórea EL, Bertolami MC, Faludi AA, Hirata RDC. CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia [Internet]. Clinica Chimica Acta. 2008 ; 398( 1-2): 15-20.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cca.2008.07.032
Artigo de periodico
Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population (2004)
Pereira, Alexandre da Costa; Schettert, Isolmar Tadeu; Morandini Filho, Antônio Alberto F.; Guerra-Shinohara, Elvira Maria ; Krieger, José Eduardo
Source: Clinica Chimica Acta. Unidades: FCF, FM, HU
Subjects: GENÉTICA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Alexandre da Costa et al. Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population. Clinica Chimica Acta, v. 340, n. 1-2, p. 99-105, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.cccn.2003.09.016. Acesso em: 06 nov. 2024.
APA
Pereira, A. da C., Schettert, I. T., Morandini Filho, A. A. F., Guerra-Shinohara, E. M., & Krieger, J. E. (2004). Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population. Clinica Chimica Acta, 340( 1-2), 99-105. doi:10.1016/j.cccn.2003.09.016
NLM
Pereira A da C, Schettert IT, Morandini Filho AAF, Guerra-Shinohara EM, Krieger JE. Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population [Internet]. Clinica Chimica Acta. 2004 ; 340( 1-2): 99-105.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cccn.2003.09.016
Vancouver
Pereira A da C, Schettert IT, Morandini Filho AAF, Guerra-Shinohara EM, Krieger JE. Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population [Internet]. Clinica Chimica Acta. 2004 ; 340( 1-2): 99-105.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cccn.2003.09.016

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Indexado em